How cells talk to adjust insulin for weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how cells in the pancreas communicate to help the body produce enough insulin when you have insulin resistance (weight-related). It tests a peptide to see how this communication works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Either your BMI is under 27 (lean) or 27 or above (overweight), and your blood sugar and A1c are within certain ranges.
- You cannot have diabetes, pancreatitis, or a family history of diabetes.
- No active infections, inflammatory, or mental health issues.
- You must have good vein access and not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This early study looks at a gut hormone–based treatment (GLP-1) and how it affects blood sugar and digestion after gastric bypass. It may help people who are having repeated low blood sugar episodes after surgery.
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.